EDUARDO LUIS
ANGUITA MANDLY

Profesor titular de universidad

Foto de EDUARDO LUIS

Foto de Hospital Virgen de la Arrixaca

Hospital Virgen de la Arrixaca

Murcia, España

Hospital Virgen de la Arrixaca -ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2023

TIM3, a human acute myeloid leukemia stem cell marker, does not enrich for leukemia-initiating stem cells in B-cell acute lymphoblastic leukemia
Haematologica

2019

Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic reconstitution and severe colitis
Haematologica, Vol. 104, Núm. 2, pp. e54-e58

2018

Correction to "Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition" [Oncotarget. 2017; 8:31959-31976]. Doi: https://doi.org/10.18632/oncotarget.16657
Oncotarget

2017

Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition
Oncotarget, Vol. 8, Núm. 19, pp. 31959-31976

2014

Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease
Haematologica, Vol. 99, Núm. 7, pp. 1168-1175